As global markets navigate a complex landscape marked by interest rate adjustments and tariff developments, investors are keenly observing the performance of major indices like the Nasdaq Composite, which recently set a fresh all-time high. Amidst these fluctuations, identifying undervalued stocks can be an effective strategy for those looking to capitalize on potential market inefficiencies.
Name
Current Price
Fair Value (Est)
Discount (Est)
Xiaocaiyuan International Holding (SEHK:999)
HK$10.22
HK$20.38
49.8%
Xi’an NovaStar Tech (SZSE:301589)
CN¥155.71
CN¥310.78
49.9%
Sparebank 68° Nord (OB:SB68)
NOK175.06
NOK348.25
49.7%
Kuros Biosciences (SWX:KURN)
CHF27.46
CHF54.72
49.8%
InPost (ENXTAM:INPST)
€13.38
€26.51
49.5%
IDI (ENXTPA:IDIP)
€79.40
€157.71
49.7%
EROAD (NZSE:ERD)
NZ$2.31
NZ$4.60
49.8%
Echo Investment (WSE:ECH)
PLN5.38
PLN10.71
49.7%
Atea (OB:ATEA)
NOK141.20
NOK281.16
49.8%
Andes Technology (TWSE:6533)
NT$274.00
NT$543.72
49.6%
Let’s dive into some prime choices out of the screener.
Overview: ACM Research (Shanghai), Inc. focuses on the research, development, production, and sale of semiconductor equipment both in China and internationally, with a market cap of CN¥51 billion.
Operations: The company’s revenue primarily comes from its Semiconductor Equipment and Services segment, generating CN¥6.48 billion.
Estimated Discount To Fair Value: 19.8%
ACM Research (Shanghai) is trading at a good value, 19.8% below its estimated fair value of CN¥146.56, with strong earnings growth of 53.8% over the past year and forecasted annual profit growth exceeding market expectations at 24.4%. Despite low return on equity forecasts and a dividend not well covered by free cash flows, recent earnings reports show substantial revenue and net income increases, underscoring its potential as an undervalued stock based on cash flows.
SHSE:688082 Discounted Cash Flow as at Aug 2025
Overview: Kuraray Co., Ltd. is involved in the global production and sale of resins, chemicals, fibers, activated carbon, and high-performance membranes and systems, with a market cap of approximately ¥544.68 billion.
Operations: The company’s revenue segments include Vinyl Acetate at ¥408.95 billion, Functional Materials at ¥203.36 billion, Isoprene at ¥78.77 billion, Fibers and Textiles at ¥61.19 billion, and Trading at ¥69.30 billion.
Story Continues
Estimated Discount To Fair Value: 43.6%
Kuraray is trading at ¥1,747, significantly below its estimated fair value of ¥3,098.28. Despite a low forecasted return on equity and profit margins dropping from 6.3% to 1.9%, the company’s earnings are expected to grow substantially at 29.4% annually, outpacing the Japanese market’s growth rate of 8.1%. Recent share buybacks further indicate confidence in its valuation and potential as an undervalued stock based on cash flows.
TSE:3405 Discounted Cash Flow as at Aug 2025
Overview: Daiichi Sankyo Company, Limited is a pharmaceutical manufacturer and seller operating in Japan, North America, Europe, and internationally with a market cap of ¥6.61 trillion.
Operations: The company generates revenue primarily from its Pharmaceutical Operation segment, which amounts to ¥1.92 trillion.
Estimated Discount To Fair Value: 41%
Daiichi Sankyo is trading at ¥3,671, considerably below its fair value estimate of ¥6,226.62, based on discounted cash flow analysis. Despite a dividend yield of 2.12% not fully covered by free cash flows and high non-cash earnings levels, the company’s earnings are projected to grow at 12.52% annually, surpassing the Japanese market’s growth rate of 8.1%. Recent product developments in oncology may enhance future revenue streams.
TSE:4568 Discounted Cash Flow as at Aug 2025
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SHSE:688082 TSE:3405 and TSE:4568.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com